NEW YORK, Dec. 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Cardiac Biomarkers Industry
http://www.reportlinker.com/p0109895/Global-Cardiac-Biomarkers-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
This report analyzes the worldwide markets for Cardiac Biomarkers in US$ Million. The market is analyzed by Location-wise (Clinical Laboratory Testing, and Point-of-Care Testing) and by Assay types (Acute Myocardial Infarction (AMI) Tests (Creatine Kinase-MB (CK-MB), Cardiac Troponin, & Myoglobin), and Congestive Heart Failure (CHF) Tests (BNP &NT-proBNP)). The report provides separate omprehensive analytics for the US, Europe, and Rest of the World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 58 companies including many key and niche players such as Abbott Diagnostics, Alere, Inc., Ani Biotech Oy, Axis-Shield PoC, Beckman Coulter, Inc., BG Medicine, biomerieux, LifeSign LLC, Nanogen Inc., Ortho-Clinical Diagnostics, Inc., Prognostix, Inc., Response Biomedical Corp., Roche Diagnostics Corp., and Siemens Healthcare Diagnostics, Inc.. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
To order this report:
Genomics Industry: Global Cardiac Biomarkers Industry
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article